Screener
Regeneron Pharmaceuticals REGN Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Regeneron Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Regeneron Pharmaceuticals’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 6:52 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000872589-26-000025
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Property, plant, and equipment, net | 5,458.9 | 5,120.4 |
| Intangible assets, net | 1,309.8 | 1,257.4 |
| Deferred tax assets | 4,381.4 | 4,077.2 |
| Other noncurrent assets | 2,306.2 | 1,821.2 |
| Total assets | $41,730.6 | $40,558.7 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $1,159.3 | $939.0 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Regeneron Pharmaceuticals's other non-current assets?
- Regeneron Pharmaceuticals (REGN) reported other non-current assets of $2.31B in Q2 2026.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Regeneron Pharmaceuticals's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude